Lipid profile during pregnancy in HIV-infected women

HIV Clinical Trials

Volumn 7, Issue 4, 2006, Pages 184-193

  Floridia, Marco ^a   Tamburrini, E ^b   Ravizza, M ^c   Tibaldi, C ^d,l   Ravagni Probizer, M F ^e   Anzidei, G ^f,l   Sansone, M ^g   Mori, F ^h   Rubino, E ^i,l   Meli, M ^j   Dalzero, S ^c   Guaraldi, G ^k   Ortolani, P ^l   Monticelli, C ^l   dalle Nogare, E R ^l   Sterrantino, G ^l   Mazzetti, M ^l   Borchi, B ^l   Vichi, F ^l   Pinter, E ^l   Anzalone, E ^l   Roberti, L ^l   Pietrogiacomi, L ^l   Carocci, A ^l   Grilli, E ^l   Maccarbruni, A ^l   Moretti, A ^l   Natalini, G ^l   Vanzini, C ^l   Sabbatini, F ^l   Nardini, G ^l   Zoncada, A ^l   Degli Antoni, A ^l   Molinari, A ^l   Rogasi, P ^l   Crisalli, M P ^l   Chiesa, E ^l   Placido, G ^l   Dallessandro, M ^l   Vivarelli, A ^l   Castelli, P ^l   Savalli, F ^l   Portelli, V ^l   Alberico, S ^l   Bernardon, M ^l   Meloni, A ^l   Citernesi, A ^l   Vimercati, A ^l   Guerra, B ^l   Ciardelli, V ^l   Martinelli, P ^l   Ladetto, L ^l   Marini, S ^l   Masuelli, G ^l   Di Lenardo, L ^l   Ferrazzi, E ^l   Conserva, V ^l   Brambilla, T ^l   Bucceri, A ^l   Matrone, R ^l   Scaravelli, G ^l   Cavallini, R ^l   Gariel, D ^l   Di Giambenedetto, S ^l   Fundaro C ^l   Genovese, O ^l   Cafforio, C ^l   Pinnetti, C ^l   Liuzzi, G ^l   Tozzi, V ^l   Massetti, P ^l   Anceschi, M ^l   Casadei, A M ^l   Montella, F ^l   Cavaliere, A F ^l   Finelli, V ^l   Riva, C ^l   Cellini, G ^l   Venturi, V ^l   Lanari, M ^l   Garetto, S ^l   Castelli Gattinara, G ^l   Mangiarotti, L ^l   Ierardi, M ^l   Foina, S ^l   Salerio, B ^l   Mattei, A ^l   Pollizi, C ^l   Germinario, E ^l   Pirillo, M F ^l   Amici, R ^l   Galluzzo, C M ^l   Floridia, M ^l   Cerioli, A ^l   De Martino, M ^l   Mastroiacovo, P ^l   more..

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d UNIVERSITY OF TURIN   (Italy)

^e FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^f NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^g UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^h Ospedale Infermi   (Italy)

ⁱ UNIVERSITY OF PALERMO   (Italy)

^j CAREGGI UNIVERSITY HOSPITAL   (Italy)

^k UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^l NONE

more..

Author keywords

Cholesterol; HIV; Pregnancy; Protease inhibitors; Triglycerides

Indexed keywords

ANTIRETROVIRUS AGENT; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PROTEINASE INHIBITOR; STAVUDINE; TRIACYLGLYCEROL;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; DISEASE COURSE; DISEASE SURVEILLANCE; DRUG MECHANISM; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERLIPIDEMIA; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; PREGNANCY; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; THIRD TRIMESTER PREGNANCY; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; CHOLESTEROL, HDL; CHOLESTEROL, LDL; FEMALE; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HIV-1; HUMANS; HYPERLIPIDEMIAS; ITALY; LIPID METABOLISM; LOGISTIC MODELS; POPULATION SURVEILLANCE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY TRIMESTERS; STAVUDINE; TREATMENT OUTCOME; TRIGLYCERIDES;

EID: 33750870241     PISSN: 15284336     EISSN: None     Source Type: Journal    
DOI: 10.1310/hct0704-184     Document Type: Article

References (17)

1. Grinspoon S, Carr A. Cardiovascular risk and body-fat abnormalities in HIV-infected adults. New Engl J Med. 2005;352(1):48-62.
2. Butte NF. Carbohydrate and lipid metabolism in pregnancy: normal compared with gestational diabetes mellitus. Am J Clin Nutr. 2000;71 (suppl):1256S-1261S.
3. Friis-Møller N, Weber R, Reiss P, et al. Cardiovascular disease risk factors in HIV-patients: association with antiretroviral therapy: results from the DAD study. AIDS. 2003;17:1179-1193.
4. Gallant JE, Staszewski S, Pozniak AL, et al. Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomised trial. JAMA 2004;292:191-201.
5. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report. Circulation. 2002;106:3143-3421.
6. Ridker PM, Rifai N, Cook NR, et al. Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women. JAMA. 2005;294:326-333.
7. Hokanson JE, Austin MA. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J Cardiovasc Risk. 1996;3(2):213-219.
8. Yadav D, Pitchumoni CS. Issues in hyperlipidemic pancreatitis. J Clin Gastroenterol. 2003;36(1):54-62.
9. Saadi HF, Kurlander DJ, Erkins JM, Hoogwerf BJ. Severe hypertriglyceridemia and acute pancreatitis during pregnancy: treatment with gemfibrozil. Endocrine Pract. 1999;5(1):33-36.
10. Enquobahrie DA, Williams MA, Qiu C, Luthy DA. Early pregnancy lipid concentrations and the risk of gestational diabetes mellitus. Diabetes Res Clin Pract. 2005;70(2):134-142.
11. Clausen T, Djurovic S, Heriksen T. Dyslipidemia in early second trimester is mainly a feature of women with early onset pre-eclampsia. BJOG. 2001;108(10):1081-1087.
12. Kitajima M, Oka S, Yasuhi I, et al. Maternal serum triglyceride at 24-32 weeks' gestation and newborn weight in nondiabetic women with positive diabetic screens. Obstet Gynecol. 2001;97:776-780.
13. Maternal triglyceride levels and newborn weight in pregnant women with normal glucose tolerance. Diabetic Med. 2005;22(1):21-25.
14. Sarner L, Fakoya A. Acute onset lactic acidosis and pancreatitis in the third trimester of pregnancy in HIV-1 positive women taking antiretroviral medication. Sex Transm Infect. 2002;78(1):58-59.
15. Blanche S, Tardieu M, Rustin P, et al. Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues. Lancet. 1999;354(9184):1084-1089.
16. Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States. February 24, 2005. Available at: http://aidsinfo.nih.gov/ guidelines/perinatal/PER_22405.pdf. Accessed June 3, 2005.
17. FDA public health advisory for nevirapine (Viramune). January 19, 2005. Available at: http://www.fda.gov/cder/drug/advisory/nevirapine.htm. Accessed July 10, 2006.